Stay updated on IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Updated the page to Revision: v3.3.2, replacing the previous v3.2.0. No core study information or documents were visibly changed.
    Difference
    0.1%
    Check dated 2025-11-25T11:23:58.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Notice about government funding and operating status was removed from the page; this change does not affect the study details, eligibility criteria, or user interactions with the trial information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:10:15.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Updated the study record to include Results First Posted on 2025-05-15 and revised related dates. The page now shows new results information and updated status details.
    Difference
    0.4%
    Check dated 2025-11-03T21:02:52.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:29:47.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T03:05:32.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    Updated revision from v3.0.1 to v3.0.2. Removed the 'Back to Top' element.
    Difference
    0.2%
    Check dated 2025-09-14T18:59:54.000Z thumbnail image

Stay in the know with updates to IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMGN853 + Pembrolizumab in Endometrial Cancer Clinical Trial page.